Stemline Therapeutics Inc. (STML) Climbed After FDA Agreement

Stemline Therapeutics Inc. (STML) announced Thursday that it reached an agreement with the FDA on a registration pathway for SL-401 in blastic plasmacytoid dendritic cell neoplasm.

from RTT - Before the Bell http://ift.tt/2jkvE9E
via IFTTT